Managers / Q2 2020 · view latest →
AMI ASSET MANAGEMENT CORP
CIK 0001369702 · 10866 WILSHIRE BLVD STE 770, LOS ANGELES, CA, 90024 · 424-320-4003
Summary
Ami Asset Management Corp reported $1.9B in U.S.-listed holdings across 81 positions for Q2 2020.
Its largest position, AAPL, represents 4.9% of the portfolio.
Compared with Q1 2020, the fund opened 7 new positions and exited 4.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 54.7% · $1.0B
- Other · 45.3% · $850M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| HALOZYME THERAPEUTIC | NEW | +526.4K | 526.4K | +$14M | $14M |
| SERVICEMASTER GLBL | NEW | +268.6K | 268.6K | +$10M | $10M |
| CNMDCONMED CORP | NEW | +88.9K | 88.9K | +$6M | $6M |
| SJMJ M SMUCKER CO | NEW | +2.3K | 2.3K | +$238,000 | $238,000 |
| ENERGIZER HOLDINGS INC N | NEW | +4.4K | 4.4K | +$210,000 | $210,000 |
| 3M CO | NEW | +1.3K | 1.3K | +$209,000 | $209,000 |
| MDLZMONDELEZ INTL CLASS A | NEW | +4.0K | 4.0K | +$205,000 | $205,000 |
| HORIZON THERAPEUTICS P F | ADDED | +447.0K | 750.2K | +$33M | $42M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.6B | 96 | Apr 23, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.8B | 91 | Jan 23, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.8B | 89 | Oct 16, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.7B | 85 | Jul 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.7B | 90 | Apr 23, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.9B | 92 | Jan 17, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.8B | 88 | Oct 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.9B | 84 | Jul 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $2.0B | 81 | Apr 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.8B | 83 | Jan 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.6B | 80 | Oct 20, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.7B | 79 | Jul 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 81 | Apr 21, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2022 | Under review | 87 | Jan 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.4B | 87 | Oct 24, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.6B | 91 | Jul 21, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.9B | 90 | Apr 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $2.1B | 97 | Jan 20, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $2.0B | 94 | Oct 22, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $2.0B | 95 | Jul 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $1.9B | 92 | Apr 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.0B | 90 | Jan 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $2.0B | 88 | Oct 23, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.9B | 81 | Jul 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.6B | 78 | Apr 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $2.0B | 81 | Jan 23, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.9B | 77 | Oct 23, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $2.0B | 70 | Aug 5, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.4B | 69 | Apr 25, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $1.2B | 73 | Jan 25, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.